EOGT


Summary: This gene encodes an enzyme that acts in the lumen of the endoplasmic reticulum to catalyze the transfer of N-acetylglucosamine to serine or threonine residues of extracellular-targeted proteins. This enzyme modifies proteins containing eukaryotic growth factor (EGF)-like domains, including the Notch receptor, thereby regulating developmental signalling. Mutations in this gene have been observed in individuals with Adams-Oliver syndrome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in EOGT


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF ISS GO:0016262 protein N-acetylglucosaminyltransferase activity
BP ISS GO:0006493 protein O-linked glycosylation
CC IEA GO:0005788 endoplasmic reticulum lumen
Showing 1 to 3 of 3 rows

Gene expression in normal tissue: EOGT

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 5

Gene-drug pathway distribution

ERK MAPK signaling2Protein stability and degradation1

Pathways in EOGT


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa00514 Other types of O-glycan biosynthesis - Homo sapiens (human)
Showing 1 to 1 of 1 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD399 Selumetinib 1
iGMDRD353 PD0325901 2
iGMDRD309 17AAG 2
Showing 1 to 3 of 3 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in EOGT

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​